I got an email from histogen on October 31st, 2012, this is what it said
As a member of the interest list for Histogen’s Hair Stimulating Complex (HSC), we are pleased to share updates from the ongoing Phase I/II clinical trial of HSC with you.
Histogen CEO Dr. Gail Naughton presented clinical results at the International Society for Hair Restoration Surgery (ISHRS) Annual Meeting on October 19th, sharing the latest information from both the current Phase I/II and the physician-sponsored trial of HSC. Attached please find Dr. Naughton’s presentation, which reveals new findings and provides compelling new photographs from the HSC trials.
While we cannot provide updates on market timelines or clinical trial recruiting at this time, I would be happy to answer any other questions related to the ongoing studies, as well as business or press-related inquiries. Please contact me directly at the email below, and I will get back to you as soon as I can.
Thank you, and hope you are well.
Eileen
As a member of the interest list for Histogen’s Hair Stimulating Complex (HSC), we are pleased to share updates from the ongoing Phase I/II clinical trial of HSC with you.
Histogen CEO Dr. Gail Naughton presented clinical results at the International Society for Hair Restoration Surgery (ISHRS) Annual Meeting on October 19th, sharing the latest information from both the current Phase I/II and the physician-sponsored trial of HSC. Attached please find Dr. Naughton’s presentation, which reveals new findings and provides compelling new photographs from the HSC trials.
While we cannot provide updates on market timelines or clinical trial recruiting at this time, I would be happy to answer any other questions related to the ongoing studies, as well as business or press-related inquiries. Please contact me directly at the email below, and I will get back to you as soon as I can.
Thank you, and hope you are well.
Eileen
Comment